Scientific American: Battling Alzheimer’s through better access to the brain

| Posted in Brain Education, Brain Research

There are tough diseases to treat, and then there’s Alzheimer’s. After years of research, billions of dollars, and several hundred clinical trials, there are five FDA-approved drugs for Alzheimer’s, none of which can sustainably treat or reverse a patient’s inexorable decline. That has left Alzheimer’s researchers trying one drug candidate after another, and almost grasping for good news. (November 2, 2018)

Read the full article here